Brief: Organon Provides Update On Phase 2 Elena Proof-Of-Concept Study Evaluating OG-6219 In Patients With Endometriosis-Related Pain

Organon & Co.

02/07/2025 12:37

July 2 (Reuters) - Organon & Co OGN.N:

ORGANON PROVIDES UPDATE ON PHASE 2 ELENA PROOF-OF-CONCEPT STUDY EVALUATING OG-6219 IN PATIENTS WITH ENDOMETRIOSIS-RELATED PAIN

ORGANON & CO - PHASE 2 STUDY ON OG-6219 DID NOT MEET PRIMARY ENDPOINT

ORGANON & CO - TO DISCONTINUE OG-6219 CLINICAL DEVELOPMENT PROGRAM

ORGANON & CO - OG-6219 DID NOT IMPROVE ENDOMETRIOSIS-RELATED PAIN COMPARED TO PLACEBO

Source text: ID:nBw3f1WtXa

Further company coverage: OGN.N

 ((Reuters.Briefs@thomsonreuters.com;))